Abbott, J&J Rise in Premarket on Covid-19 Treatment Hopes By

© Reuters.

By Geoffrey Smith — Stocks in focus in premarket trade on Monday, March 30th. 

  • Johnson & Johnson (NYSE:) stock was up 4.5% after the company said it plans to start testing its experimental coronavirus vaccine on humans by September, with an eye to having it approved for use early next year. the drugmaker said on Monday.
  • J&J also said it will invest than $1 billion together with U.S. agency Biomedical Advanced Research and Development Authority (BARDA) to co-fund vaccine research.
  • Abbott Labs (NYSE:) stock was up 9.9% after the company said the Food and Drug Administration has issued Emergency Use Authorization for a Covid-19 test that it says can deliver positive results in as little as five minutes and negative ones in less than a quarter of an hour.
  • Oil and gas stocks were generally struggling with another sharp drop in the price of after President Donald Trump pushed back the timeline for lifting current advice restricting non-essential consumption.
  • Occidental Petroleum (NYSE:) stock was down 4.7% while Exxon Mobil (NYSE:) stock was down 2.6% and Chevron (NYSE:) stock was down 2.3%
  • Among independent shale producers, Pioneer Natural Resources (NYSE:) was down 5.3% while Continental  (NYSE:) was down 4.8%.
  • Carnival (NYSE:) stock was down 7.4% after the cruise line operator struggled to contain an outbreak of Covid-19 on another of its ships, the Holland America.
  • Zoom Video Communications (NASDAQ:) stock was up another 5.1% after a 7.5% rise on Friday as investors continued to pour into the ultimate ‘working-from-home’ beneficiary.
  • The maker of videoconferencing software is now valued at $42 billion, or over 56 times last year’s sales, spurring talk of an unsustainable bubble.
  • Slack Technologies (NYSE:) stock was up 4.5% at its highest since August, another play on the boom in remote working, albeit at a less stretched multiple of 25 times trailing 12-month sales.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.